Research Article
An Assessment of Cardiovascular Health Risks in People Working from Home During the Pandemic Period: PANDEV-KALP Study
Abstract
Background: The COVID-19 pandemic resulted in people working from home (WFH), which is associated with negative mental and social effects. However, the cardiovascular effects are not well established. We aimed to assess the effects of WFH on cardiovascular risk factors and health behaviors during the COVID-19 pandemic.
Methodology: Companies that employ WFH were invited to study via occupational health specialists. WFH employees were sent an online self-reported questionnaire, which included demographics, WFH conditions, medical history, new-onset complaints, and health behaviors. Participants were asked to provide data on blood pressure, glucose, and lipid levels before and during the pandemic.
Results: 208 participants completed the questionnaire, and 61 provided biological data. 72 participants reported to have undergone training for WFH conditions, and 87 were able to provide regular breaks. Weekly working hours have increased by 6 hours during the pandemic (49.6±13.8 vs. 43.8±12.1, p=0.001). Participants reported a median 7.5/10 satisfaction regarding WFH. 112 (53.8%) participants had a new complaint; the most common complaints were body weight gain/increased appetite (35.1%), insomnia/anxiety (27.9%), and physical inactivity/ musculoskeletal pain (18.3%). 120 (57.6%) participants had a weight increase. Most participants did not have changes in tobacco or alcohol consumption or exercise habits during the pandemic. Data from the biological data subgroup did not show significant changes in blood pressure, blood glucose, or lipid levels.
Conclusion: WFH adversely affected modifiable cardiovascular risk factors and was associated with weight gain, increased work hours, a lack of workload planning, and increased anxiety. Although risk factors are adversely affected by WFH conditions, workers were satisfied with WFH. The training rate regarding WFH conditions was low; training about WFH should be provided to related employees, and occupational health specialists should focus on reducing specific risk factors that exist during WFH.
Ethical Statement
The survey was performed via an online platform that was developed for and dedicated to PANDEV-KALP Study. Each patient in the study was assigned an anonymous identification number to protect confidentiality. Written informed consent was obtained prior to the study inclusion. The study complies with the principles outlined in the Declaration of Helsinki, and this study protocol was approved by the Clinical Research Ethics Committee of Marmara University (Approval No: 09.2021.646).
Supporting Institution
The PANDEV-KALP research project was partially supported by an unrestricted research grant provided by AXA Insurance Turkey, following the decision of its Board of Directors dated April 28, 2021.
Thanks
We dedicate this work to the memory of our esteemed colleague, Dr. M. Rıfat Yücel. After retiring from the Department of Physiology at Cerrahpaşa Medical Faculty, Dr. Yücel continued his professional contributions at Tez Medikal Joint Occupational Health and Safety Unit (OSGB). He was widely respected within the medical community for his dedication, hard work, and collegial spirit. He was also amongst the researchers in this study. Dr. Yücel passed away on December 19, 2021, due to COVID-19. We remember him with deep respect, gratitude, and affection.
References
- 1. Galanti T, Guidetti G, Mazzei E, Zappalà S, Toscano F. Work from home during the COVID-19 outbreak: the impact on employees’ remote work productivity, engagement, and stress. J Occup Environ Med. 2021;63(7):e426-e432. doi:10.1097/ JOM.0000000000002236.
- 2. Chu AMY, Chan TWC, So MKP. Learning from work-from-home issues during the COVID-19 pandemic: balance speaks louder than words. PLoS One. 2022;17(1):e0261969. doi:10.1371/journal. pone.0261969.
- 3. Wang B, Liu Y, Qian J. Achieving effective remote working during the COVID-19 pandemic: a work design perspective. Applied Psychol. 2021;70(1):16-59. doi:10.1111/apps.12290.
- 4. Nordenmark M, Vinberg S. Working from home, work/ life conflict and mental wellbeing in Europe during the COVID-19 pandemic. Work. 2024;78(2):295–304. doi:10.3233/WOR-230271.
- 5. Rohail I. Impact of lockdown due to COVID-19 pandemic on general public in Pakistan. Foundation University Journal of Psychology. 2020;4(2):5-10. doi:10.33897/fujp.v4i2.186.
- 6. Sundarasen S, Chinna K, Kamaludin K, Nurunnabi M, Baloch GM, Khoshaim HB, et al. Psychological impact of COVID-19 and lockdown among university students in Malaysia: implications and policy recommendations. Int J Environ Res Public Health. 2020;17(17):6206. doi:10.3390/ijerph17176206.
- 7. Gupta R, Grover S, Basu A, Krishnan V, Tripathi A, Subramanyam A, et al. Changes in sleep pattern and sleep quality during COVID-19 lockdown. Indian J Psychiatry. 2020;62(4):370-378. doi:10.4103/ psychiatry.IndianJPsychiatry_523_20.
- 8. Fan M, Sun D, Zhou T, Heianza Y, Lv J, Li L, et al. Sleep patterns, genetic susceptibility, and incident cardiovascular disease: a prospective study of 385 292 UK biobank participants. Eur Heart J. 2020;41(11):1182- 9. doi:10.1093/eurheartj/ehz849.
- 9. Steptoe A, Kivimäki M. Stress and cardiovascular disease. Nat Rev Cardiol. 2012;9(6):360-70. doi:10.1038/ nrcardio.2012.45.
- 10. Elagizi A, Kachur S, Carbone S, Lavie CJ, Blair SN. A review of obesity, physical activity, and cardiovascular disease. Curr Obes Rep. 2020;9(4):571-81. doi:10.1007/s13679-020-00403-z.
- 11. Teo KK, Rafiq T. Cardiovascular risk factors and prevention: a perspective from developing countries. Can J Cardiol. 2021;37(5):733-43. doi:10.1016/j. cjca.2021.02.009.
- 12. Di Fusco SA, Spinelli A, Castele L, Mocini E, Gulizia MM, Oliva F, et al. Impact of working from home on cardiovascular health: an emerging issue with the COVID-19 pandemic. Int J Environ Res Public Health. 2021;18(22):11882. doi:10.3390/ijerph182211882.
- 13. Haidar A, Horwich T. Obesity, cardiorespiratory fitness, and cardiovascular disease. Curr Cardiol Rep. 2023;25(11):1565-71. doi:10.1007/s11886-023- 01975-7.
- 14. Furuya Y, Nakazawa S, Fukai K, Tatemichi M. Health impacts with telework on workers: a scoping review before the COVID-19 pandemic. Front Public Health. 2022;10:981270. doi:10.3389/fpubh.2022.981270.
- 15. Zaitsu M, Ishimaru T, Tsushima S, Muramatsu K, Ando H, Nagata T, et al. Incidence of coronary heart disease among remote workers: a nationwide web-based cohort study. Sci Rep. 2024;14(1):8415. doi:10.1038/s41598- 024-59000-y.
- 16. Kivimäki M, Jokela M, Nyberg ST, Singh-Manoux A, Fransson EI, Alfredsson L, et al. Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603838 individuals. Lancet. 2015;386(10005):1739-46. doi:10.1016/S0140- 6736(15)60295-1.
- 17. Dor-Haim H, Katzburg S, Revach P, Levine H, Barak S, et al. The impact of COVID-19 lockdown on physical activity and weight gain among active adult population in Israel: a cross-sectional study. BMC Public Health. 2021;21(1):1521. doi:10.1186/s12889-021-11523-z.
- 18. Begum F, Said J, Hossain SZ, Ali MA. Patient satisfaction level and its determinants after admission in public and private tertiary care hospitals in Bangladesh. Front Health Serv. 2022;2:952221. doi:10.3389/ frhs.2022.952221.
- 19. Mutiarasari D, Demak IPK, Bangkele EY, Nur R, Setyawati T. Patient satisfaction: public vs. private hospital in Central Sulawesi, Indonesia. Gac Sanit. 2021;35 Suppl 2:S186-90. doi:10.1016/j. gaceta.2021.07.012.
- 20. Broad J, Wells S, Marshall R, Jackson R. Zero enddigit preference in recorded blood pressure and its impact on classification of patients for pharmacologic management in primary care–PREDICTCVD- 6. Br J Gen Pract. 2007;57(544):897-903. doi:10.3399/096016407782317964.
- 21. Carnethon M, Whitsel LP, Franklin BA, Kris-Etherton P, Milani R, Pratt CA, et al. Worksite wellness programs for cardiovascular disease prevention: a policy statement from the American Heart Association. Circulation. 2009;120(17):1725-41. doi:10.1161/ CIRCULATIONAHA.109.192653.
There are 21 citations in total.
Details
| Primary Language | English |
|---|---|
| Subjects | Internal Diseases |
| Journal Section | Research Article |
| Authors | |
| Submission Date | October 15, 2025 |
| Acceptance Date | December 17, 2025 |
| Early Pub Date | January 19, 2026 |
| Publication Date | January 19, 2026 |
| Published in Issue | Year 2026 Issue: Advanced Online Publication |
Cite
Aim & Scope
DAHUDER Medical Journal (DAHUDER MJ) is an international, independent, double-blind peer-reviewed, open access, and online publishing journal dedicated to publishing high-quality scientific papers in all areas of clinical medicine. Manuscripts must present original data that have not been published previously and are not under consideration elsewhere.
All submissions are evaluated by at least two independent reviewers who are specialists in the relevant field, and the final decision rests with the Editor-in-Chief. The Editorial Board follows the principles of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), and the Committee on Publication Ethics (COPE).
The journal is published quarterly in March, June, September, and December and accepts manuscripts in English, including original articles, case reports, invited reviews, and letters to the editor.
Subject areas covered by DAHUDER MJ include, but are not limited to:
- Cancer and Experimental Cancer Research
- Cardiology and Clinical Cardiovascular Research
- Chest Diseases and Respiratory Medicine
- Clinical Endocrinology and Metabolic Disorders
- Clinical Pathology, Hematology, and Immunology
- Clinical Nutrition, Dietetics, and Nutritional Research
- Critical Care and Emergency Medicine
- Experimental Microbiology and Infectious Diseases
- Gastroenterology and Hepatology
- Genetics and Geriatrics
- General and Internal Medicine
- Nephrology and Rheumatology
- Oncology and Clinical Cancer Research
Author Guidelines
General information
- DAHUDER Medical Journal (DAHUDER MJ) is an international, double-blind, peer-reviewed scientific journal that publishes manuscripts describing clinical research in medicine.
- Manuscripts must describe original data that have not been published previously nor submitted for publication elsewhere.
- Manuscripts that adhere to the DAHUDER MJ submission guidelines and are deemed appropriate for the scope of the journal are sent to two reviewers who are specialists in the field.
- The members of the Editorial Board who discuss the suitability then consider the reviewers’ comments on each submission.
- The final decision for all submitted manuscripts rests with the Editor-in-Chief.
- DAHUDER MJ is a journal published four times a year in March, June, September, and December.
- Manuscripts to be published must be sent via the “Submit Article” page.
- The language of the articles is English.
Article Submission Phase
Required files to be uploaded when submitting an article:
1- A Word file of the article prepared in accordance with the editorial guidelines (No information about the authors should be included. This file will be sent to the reviewers in accordance with the double-blind review policy.)
2- The "Title Page" must be completely filled out and uploaded to the system.
3- Copyright Agreement and Author Acknowledgement Form
4- A similarity report must be uploaded to the system.
1- A Word file of the article prepared in accordance with the editorial guidelines (No information about the authors should be included. This file will be sent to the reviewers in accordance with the double-blind review policy.)
2- The "Title Page" must be completely filled out and uploaded to the system.
3- Copyright Agreement and Author Acknowledgement Form
4- A similarity report must be uploaded to the system.
5- The approved version of the Ethics Committee Permit must be uploaded to the system. If the study does not require ethics committee approval, upload a file indicating this. In addition, this approval (name, date, and number of the committee) must be stated in the "Article Information Form" at the end of the study.
Institutional review board/ethics committee approval (IRB)
If a study involves either human subjects, human-derived materials, and/or medical records, authors must include in the Methods section either a statement that an Institutional Review Board (IRB)/Ethics Committee approval has been obtained or a statement that the IRB/Ethics Committee has ruled that approval was not required for the study. When reporting experiments conducted with humans, it is indicated that the procedures were in accordance with ethical standards set forth by the committee that oversees human experimentation. Approval of research protocols by the relevant ethics committee, in accordance with international agreements (Helsinki Declaration of 1975, revised 2024, available at https://www.wma.net/policies-post/wma-declaration-of-helsinki/, “Guide for the Care and Use of Laboratory Animals” www.nap.edu/catalog/5140.html/), is required for all experimental, clinical, and drug studies. Patient names, initials, and hospital identification numbers should not be used. Manuscripts reporting the results of experimental investigations conducted with humans must state that the study protocol received institutional review board approval and that the participants provided informed consent.
Permissions
Authors who wish to include figures, tables, or text fragments that have been previously published elsewhere should definitely cite the relevant place in the article. If not cited, they must obtain permission from the copyright holder(s) for the relevant portion and include proof of such permission when submitting their manuscript. Without such proof, any material cited will be assumed to belong to the authors. No material, such as clinical images or charts, photos, and graphs, as well as images of devices that may have been obtained from their producers, can be published without such permission.
Types of Papers
All papers published by the DAHUDER Medical Journal are peer-reviewed.
Original Article: An article is a full-length report on original primary research that will interest the journal's readers. They must describe significant and original observations.
Review Article: The review article is a comprehensive analysis of specific topics and recent developments in a particular area. A review should focus on recent research and issues. It should also include the authors' opinions on how to approach the topic/situation under discussion and what is needed to advance the field in the future.
Communications: Short (brief) communications are short papers that focus on a particular aspect of a problem or a new finding that is expected to have a significant impact and present original and important material. Short communication is not intended to publish preliminary results. They may be given rapid publication. Short communication should not be subdivided. The paper should include an abstract, main body of text (combined methods, results, and discussion in a single section), and references.
Rapid communications are similar to short communications. These are usually articles used to disseminate preliminary results that are original, of high interest, and likely to have a significant impact on the relevant scientific community. In the healthcare field, this can include information that is urgent from a public health perspective or findings in a rapidly changing specialty. Their format is similar to short communications.
Case Report: Case reports and case studies should present significant new insights or cases with an unusual and noteworthy course. It is recommended that case reports include an up-to-date review of all previous cases in the field. The novelty of the case(s) may lie in the phenotype, the presentation, the investigation, and/or the management. Case reports may be from the year the article was submitted or the previous year. Case reports from earlier years will not be considered for review. A case report must be strictly limited to 750 words, excluding the abstract, and have minimal figures, tables, and references.
Letter to the Editor: Formal commentary on published articles may take the form of critiques, requests for clarification, or—on occasion—replication efforts. After peer review, these contributions may be posted online as Letters to the Editor, typically accompanied by a response from the original authors. Letters to the Editor and replies are bidirectionally linked with the original published paper. The journal will not consider Letters about work published elsewhere. Submissions that do not meet our guidelines will not be taken forward. Letters to the Editor should be roughly 750 words in length, not counting references. They must be written in a neutral register, and all points raised should pertain directly to the original article. All such submissions are peer reviewed, and the Editor retains sole discretion over acceptance or rejection.
Manuscript preparation
- Articles should be written in a single line using Microsoft Word, leaving 2.5 cm margins on all sides.
- Paragraphs should not be indented.
- A full-length article should be no more than 6,000 words, excluding references and tables.
- For equations, use either the equation editor or MathType.
- For tables, use the table function, not spreadsheets.
Download the WORD file for the sample file.
Title: A title that describes the article and is not too long is preferred. Only the first letter of each word in the title should be capitalized.
Authors: Author names must be clearly written. Abbreviations must not be used. Each author's ORCID ID number must be written. Each author's institution must be listed in the order Department, Faculty, University, City, and Country. If the institution is present, its ROR ID must be written after the address.
Abstracts: A structured abstract of no more than 250 words is required. The Abstract for all manuscripts except case reports and review articles should be divided into Background, Methods, Results, and Conclusions.
Keywords: Keywords are required for indexing and abstracting services. Up to ten words should be listed.
Main text: The main text of an original article should be divided into INTRODUCTION, METHODS, RESULTS, DISCUSSION, and CONCLUSION sections. The case report should include an abstract, introduction, case report, discussion, and references. Abbreviations must be defined following their first use in the Abstract as well as in the main text and in the figures and tables. Only commonly accepted abbreviations should be used. Drug and chemical names should be stated using generic or standard chemical nomenclature. Units of measurement should conform to the International System (SI); however, clinical data may be presented in conventional units where deemed more appropriate.
Headings and subheadings: Main headings (INTRODUCTION, METHODS, RESULTS, DISCUSSION, etc.) and the word REFERENCES should be written in capital letters. In subheadings, only the first letter of each word should be capitalized.
Footnotes: Footnotes may be used to give additional information, but should not consist of a reference citation, which is not included in the reference list at the end of the manuscript, and must not contain figures or tables. Footnotes should be numbered consecutively and separately for the title page, the main text, and each table. Footnotes should be indicated by superscript lowercase letters or numbers, or by asterisks for significance values and other statistical data. Footnotes should be positioned at the bottom of the page or table in which they appear.
Tables, Graphics, and Illustrations
Tables, graphics, and illustrations should be numbered in Arabic numerals in the text. The places of the illustrations should be signed in the text.Tables
- Tables capture information concisely and display it efficiently; they also provide information at any desired level of detail and precision. Including data in tables rather than text frequently makes it possible to reduce the length of the text.
- Tables must be numbered consecutively in the order in which they appear in the text (e.g., Table 1, Table 2, …). Table titles should be placed above the table in Times New Roman, 10-point font size. Table content should be written in Times New Roman, 10-point font size. If the table does not fit within the page, the font size may be reduced accordingly. Statistically significant values should be presented in bold. If the table has a source, it must be indicated below the table in Times New Roman, 9–10-point font size. Only the first letter of the first word in the table title should be capitalized. All other words should be lowercase (except for proper nouns).
- Authors should include explanatory information as notes below the table, not in the title.
- Be sure that each table is cited in the text. If you use data from another published or unpublished source, obtain permission and acknowledge that source fully.
- Additional tables containing backup data too extensive to publish in print may be appropriate for publication in the electronic version of the journal, deposited with an archival service, or made available to readers directly by the authors. An appropriate statement should be added to the text. Such tables should be submitted for consideration with the paper so that they will be available to the peer reviewers.
Illustrations (Figures)
- Figures should be either professionally drawn and photographed or submitted as digital prints in photographic quality. In addition to requiring a version of the figures suitable for printing, authors are asked for electronic files of figures in a format (for example, JPEG or GIF) that will produce high-quality images in the Web version of the journal; authors should review the images of such files on a computer screen before submitting them to be sure they meet their own quality standards.
- For X-ray films, scans, and other diagnostic images, as well as pictures of pathology specimens or photomicrographs, sharp, glossy, black-and-white or color photographic prints should be sent, usually 127 x 173 mm. Letters, numbers, and symbols on figures should therefore be clear and consistent throughout, and large enough to remain legible when the figure is reduced for publication.
- Figures should be made as self-explanatory as possible, since many will be used directly in slide presentations.
- Titles and detailed explanations belong in the legends--not on the illustrations themselves.
- Photomicrographs should have internal scale markers. Symbols, arrows, or letters used in photomicrographs should contrast with the background.
- Photographs of potentially identifiable people must be accompanied by written permission to use the photograph.
- Figures should be numbered consecutively according to the order in which they have been cited in the text.
- If a figure has been published previously, the original source should be acknowledged, and written permission from the copyright holder should be submitted to reproduce the figure. Permission is required irrespective of authorship or publisher, except for documents in the public domain. Accompanying drawings marked to indicate the region to be reproduced might be useful to the editor.
Legends for Illustrations (Figures)
- For image captions, Arabic numerals corresponding to the images should be used.
- When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, each one should be clearly identified and explained in the legend. The internal scale should be explained, and the method of staining in photomicrographs should be identified. Only the first letter of the first word in the figure title should be capitalized. All other words should be lowercase (except for proper nouns).
- Figure titles should be placed below the figure in Times New Roman, 10-point font size. If the figure does not fit within the page, the font size may be reduced accordingly.
- If the figure has a source, it must be indicated below the title in Times New Roman, 10-point font size. Only the first letter of the first word in the figure title should be capitalized. All other words should be lowercase (except for proper nouns).
Article Information Form
The article information form should be written after the text, before the references. Explain the following headings in detail.
Financial Disclosure:
Conflicts of interest:
Ethical Declaration:
Artificial Intelligence Statement:
Author Contributions: (The statement "Authors' contribution to the article is equal" is not accepted.) To be considered as an author of an article, a writer must have contributed to at least 3 of the following. If any of the following headings are not relevant to your work, please mark them as "None".
Conceptualization: F.A., S.A.;
Methodology: F.A., S.A.;
Software: T.A.;
Validation: F.A., T.A.;
Formal analysis: S.A.;
Investigation: F.A.;
Resources: T.A.;
Data curation: F.A.;
Writing – original draft: S.A.;
Writing – review & editing: F.A.;
Visualization: S.A.;
Supervision: None;
Project administration: F.A., S.A.;
Funding acquisition: None.;
Conceptualization: F.A., S.A.;
Methodology: F.A., S.A.;
Software: T.A.;
Validation: F.A., T.A.;
Formal analysis: S.A.;
Investigation: F.A.;
Resources: T.A.;
Data curation: F.A.;
Writing – original draft: S.A.;
Writing – review & editing: F.A.;
Visualization: S.A.;
Supervision: None;
Project administration: F.A., S.A.;
Funding acquisition: None.;
Reference Style and Format
- References in the article should be written in Vancouver style.
- References should be shown in square brackets, for example [1], [2,3], [4-8].
- References should be numbered consecutively in the order in which they are first mentioned in the text. Identify references in text, tables, and legends by Arabic numerals in parentheses. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure.
- The titles of journals should be abbreviated according to the style used in the list of Journals in Index Medicus. Additionally, the list should be obtained from the web address http://www.nlm.nih.gov. If a journal is not indexed in Index Medicus, it should not be abbreviated.
- If there are more than 6 authors, write the first 6 authors according to the rule and use et al. for the subsequent authors.
- All references should be cited in text.
- Citing a "personal communication" should be avoided unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text. For scientific articles, written permission and confirmation of accuracy from the source of a personal communication must be obtained.
- Accuracy of citation is the author's responsibility. Type references in the style shown below.
For journals
Articles in journals
For the published article from the journal, which is placed and abbreviated in Medline:
- Godoy DA, Behrouz R, Di Napoli M. Glucose control in acute brain injury: does it matter? Curr Opin Crit Care. 2016;22(2):120-7. doi:10.1097/MCC.0000000000000292.
- Ahluwalia V, Heuman DM, Feldman G, Wade JB, Thacker LR, Gavis E, et al. Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis. J Hepatol. 2015;62(1):75-82. doi:10.1016/j.jhep.2014.07.033.
- Schwandt A, Harris PJ, Hunsberger S, Deleporte A, Smith GL, Vulih D, et al. The role of age on dose-limiting toxicities in phase I dose-escalation trials. Clin Cancer Res. 2014;20(18):4768-75. doi:10.1158/1078-0432.CCR-14-0866. Epub 2014 Jul 15.
- Morehouse R, Macqueen G, Kennedy SH. Barriers to achieving treatment goals: a focus on sleep disturbance and sexual dysfunction. J Affect Disord. 2011;132(Suppl 1):S14-20. doi:10.1016/j.jad.2011.03.047.
For the published article from the journal that is not placed and is not abbreviated in Medline:
- Seremet Kürklü N, Suna G, Kamarlı Altun H, Karaçil Ermumcu MŞ. The state of vitamin D supplement use and knowledge levels of mothers with 0–12 month-old infants. Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi. 2022;4(2):94-102. doi:10.46413/boneyusbad.1073447.
Articles in press
- Shen Y, Hung C. Intranasal esketamine for treatment-resistant depression with structural brain abnormality: a case report. Psychiatry Clin Psychopharmacol. 2025. In press. doi:10.5152/pcp.2025.251248.
- Fortea A, Ortuño M, Masias M, Guasp M, De la Serna E, Armangue T, et al. Brain metabolite levels in the post-acute stage of anti-NMDA receptor encephalitis and schizophrenia: a longitudinal case-control study. Biol Psychiatry. 2025. In press.
Article with published erratum
- Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330–9. doi:10.1001/jamaoncol.2015.4508. Erratum in: JAMA Oncol. 2016;2(9):1244. doi:10.1001/jamaoncol.2016.2968.
- Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):762–774. doi:10.1001/jama.2016.0288. Erratum in: JAMA. 2016;315(20):2237. doi:10.1001/jama.2016.5850.
Volume with supplement
- Nast A, Dreno B, Bettoli V, Degitz K, Erdmann R, Finlay AY, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26(Suppl 1):1–29.
Issue with supplement
- Pagsberg AK. Schizophrenia spectrum and other psychotic disorders. Eur Child Adolesc Psychiatry. 2013;22(1 Suppl):S3–9.
Volume with part
- Pilegaard H, Saltin B, Neufer PD. Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol. 2003;546(Pt 3):851–8.
Issue with part
- Kamili S. Infectivity and vaccination efficacy studies in animal models of HBV S and pol gene mutants. Antivir Ther. 2010;15(3 Pt B):477–85.
Issue with no volume
- Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop Relat Res. 2002;(401):230–8.
No volume or issue
- Childhood obesity: strategies for prevention. NIH Research Brief. 2010 Jul:3-9.
Journal article on the Internet
- Hoek W, Schuurmans J, Koot HM, Cuijpers P. Effects of internet-based guided self-help problem-solving therapy for adolescents with depression and anxiety: randomized controlled trial. PLoS One [Internet]. 2012 Aug 31 [cited 2025 Sep 27];7(8):e43485. Available from: https://doi.org/10.1371/journal.pone.0043485
For books and other monographs
Personal author(s)
- Celentano DD, Szklo M. Gordis epidemiology. 6th ed. Philadelphia (PA): Elsevier; 2019.
- Petrie A, Sabin C. Medical statistics at a glance. 4th ed. Chichester (UK): Wiley-Blackwell; 2019.
Author(s) and editor(s)
- Darwin C. The origin of species by means of natural selection. Burrow JW, editor. London: Penguin; 1985.
- Kant I. Critique of pure reason. Guyer P, Wood AW, editors. New York (NY): Cambridge University Press; 1998.
Organization(s) as author
- World Health Organization. World malaria report 2023. Geneva: World Health Organization; 2023. 283 p.
Editor(s), compiler(s) as author
- Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison’s principles of internal medicine. 20th ed. New York (NY): McGraw-Hill Education; 2018.
- Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 9th ed. Philadelphia (PA): Elsevier; 2020
Translated book
- Kant I. Critique of pure reason. Guyer P, Wood AW, translators. Cambridge (UK): Cambridge University Press; 1998.
- Nietzsche F. Beyond good and evil. Hollingdale RJ, translator. London: Penguin Books; 2003.
Chapter in a book
- Grundy E, Murphy M. Demography and public health. In: Detels R, Gulliford M, Karim QA, Tan CC, editors. Oxford textbook of global public health. 6th ed. Oxford (UK): Oxford University Press; 2015. p. 718–735.
- Adkinson NF. Drug allergy. In: Middleton E, Reed CE, Ellis EF, et al., editors. Allergy: principles and practice. 5th ed. St Louis (MO): Mosby; 2002. p. 1212–1224..
Conference proceedings
- Qi E, Shen J, Dou R, editors. Proceedings of the 21st International Conference on Industrial Engineering and Engineering Management 2014; 2014 Nov 1–2; Zhuhai, China. Paris: Atlantis Press; 2015.
- Halliday RB, Walter DE, Proctor HC, Norton RA, Colloff MJ, editors. Acarology: Proceedings of the 10th International Congress; 1998 Jul 5–10; Canberra, Australia. Melbourne: CSIRO Publishing; 2001.
Dissertation (Thesis)
- Bansal Y. Building the theoretical foundations of deep learning: an empirical approach [dissertation]. Cambridge (MA): Harvard University Graduate School of Arts and Sciences; 2022.
- Sürer S. From space to safety: flood mapping with Sentinel-1 SAR data for enhancing flood risk management in Ljungby Municipality [master’s thesis]. Lund (SE): Lund University; 2024 [Internet]. [cited 2025 Nov 22]. Available from: https://lup.lub.lu.se/student-papers/record/9158441
- Patwary MM. Adoption of mobile banking applications: a study on young people [master’s thesis]. Eskişehir (TR): Anadolu University Graduate School of Social Sciences; 2017 [Internet]. [cited 2025 Nov 22]. Available from: https://doi.org/10.13140/RG.2.2.35579.49446
Poster(s)
- Gianelli C, Kühne K, Rugani R. Numerical magnitude spatially biases unusual responses [poster]. Presented at: 20th Conference of the European Society for Cognitive Psychology (ESCoP); 2017 Sep 3–6; Potsdam, Germany.
- Özge D, Vidinli D, Küntay A, Snedeker J. When you eat from the cake, is it all gone? Morphosyntax as a cue to partitivity [poster]. Presented at: 42nd Boston University Conference on Language Development (BUCLD 42); 2017 Nov 3–5; Boston, MA, USA.
Patent
- Anders K, Fox JR, Harpur LS, Dunne J, inventors; International Business Machines Corp, assignee. Social media toxicity analysis. United States patent US 11,138,237. 2021 Oct 5.
Homepage/Website
- Eurostat [Internet]. Luxembourg (LU): Statistical Office of the European Union; c1953– [cited 2025 Sep 27]. Available from: https://ec.europa.eu/eurostat
Proofreading
After DAHUDER MJ has prepared the layout of the article, it is sent to all authors for proofreading. All authors must view the pre-publication version of the article and approve its publication.
After DAHUDER MJ has prepared the layout of the article, it is sent to all authors for proofreading. All authors must view the pre-publication version of the article and approve its publication.
Multicenter clinical trials
DAHUDER MJ welcomes the submission of manuscripts reporting results of multicenter clinical trials. These manuscripts may be submitted with authorship in one of the following styles:
• The name of a study group only (collective authorship)
• The names of no more than five individuals and the name of a study group
In each case, one individual must serve as the corresponding author, and the names of all individuals specifically involved in the preparation of the manuscript should be listed under the heading Writing Committee following the Acknowledgments section. This should be followed by a list of investigators from each institution under the heading Study Group Investigators. Each author and each Writing Committee member must sign the Copyright Agreement and Author Acknowledgement Form.
Content responsibility
Content and scientific accuracy of all manuscripts, as well as of any electronic supplementary material, are the sole responsibility of the authors. No responsibility will be assumed by DAHUDER MJ for any legal claim arising from injury and/or damage to persons or property as a matter of product liability, negligence, or other circumstances; nor from any use or operation of any methods, products, instructions, or ideas contained in the published material. No test or procedure should be carried out unless the reader judges it to be safe. Independent verification of all diagnoses and drug dosages should be performed. Discussions, views, and recommendations regarding medical procedures, drug choices, and dosages are the sole responsibility of the authors.
Content and scientific accuracy of all manuscripts, as well as of any electronic supplementary material, are the sole responsibility of the authors. No responsibility will be assumed by DAHUDER MJ for any legal claim arising from injury and/or damage to persons or property as a matter of product liability, negligence, or other circumstances; nor from any use or operation of any methods, products, instructions, or ideas contained in the published material. No test or procedure should be carried out unless the reader judges it to be safe. Independent verification of all diagnoses and drug dosages should be performed. Discussions, views, and recommendations regarding medical procedures, drug choices, and dosages are the sole responsibility of the authors.
Disclaimer
Although all advertising material in DAHUDER MJ is expected to conform to ethical (medical) standards, its inclusion in this publication does not constitute a guarantee or endorsement by DAHUDER MJ regarding the quality or value of any product or of the claim made for it by its manufacturer.
Although all advertising material in DAHUDER MJ is expected to conform to ethical (medical) standards, its inclusion in this publication does not constitute a guarantee or endorsement by DAHUDER MJ regarding the quality or value of any product or of the claim made for it by its manufacturer.
Ethical Principles and Publication Policy
Section A: Publication and Authorship
1. All submitted manuscripts are evaluated through a double-blind peer-review process by at least two independent reviewers who are experts in the field. Reviewers are selected by the Associate Editors and Editor-in-Chief.
2. Review criteria include relevance, originality, scientific rigor, methodological accuracy, statistical validity, readability, and language quality.
3. The editorial decisions may include acceptance, minor revision, major revision, or rejection.
4. A request for revision does not guarantee acceptance.
5. Rejected manuscripts will not be re-evaluated.
6. Manuscript acceptance depends on compliance with ethical and legal standards regarding libel, copyright infringement, and plagiarism.
7. The same research may not be published in more than one journal or in multiple formats.
Section B: Authors’ Responsibilities
1. Authors must certify that their manuscript is original and not previously published or under review elsewhere.
2. All authors must have made significant contributions to the research and writing, as defined in the “Authors’ Contributions” section.
3. Authors are required to participate in the peer-review process and respond to reviewers’ comments in a timely and scholarly manner.
4. Authors must ensure that all data are accurate, authentic, and reproducible.
5. Any form of plagiarism, data fabrication, or image manipulation is strictly prohibited.
6. Authors must disclose any conflicts of interest or financial relationships that may influence the results or interpretation of their manuscript.
7. All sources and funding relevant to the research must be acknowledged.
8. Authors are responsible for correcting errors or retracting papers if significant issues are identified after publication.
9. Authors must not withdraw their manuscripts after submission or during the review process without the consent of the editorial board.
10. The corresponding author acts as the primary contact and is responsible for ensuring compliance with publication ethics.
Section C: Peer Review and Reviewers’ Responsibilities
1. Reviewers must treat all manuscripts as confidential and should not share, copy, or discuss their contents with others.
2. Reviews should be objective, evidence-based, and constructive, avoiding personal criticism.
3. Reviewers must declare any potential conflicts of interest (e.g., competitive, collaborative, or financial relationships).
4. Reviewers should identify any uncited relevant literature or similarity with other works known to them.
5. If serious ethical concerns (e.g., plagiarism or duplicate submission) arise, reviewers should inform the Editor-in-Chief immediately.
6. Reviewers are expected to complete their evaluations within the agreed timeframe and provide clear, reasoned feedback.
Section D: Editorial Responsibilities
1. Editors have full authority to accept or reject manuscripts based on scientific merit and journal scope.
2. Editorial decisions are made independently of personal, institutional, or financial interests.
3. Editors ensure that all published content meets international ethical standards (COPE, ICMJE, WAME).
4. Editors must maintain confidentiality of manuscripts and reviewers’ identities (in double-blind review).
5. Editors must publish errata, corrections, or retractions when necessary.
6. Editors are responsible for monitoring potential research misconduct and following COPE flowcharts for resolution.
7. Editors should base their decisions on the importance, originality, clarity, and contribution of the work.
8. Editors must not reverse previous editorial decisions without clear justification.
9. Editors must avoid and declare any conflicts of interest with authors, reviewers, or institutions.
10. The editorial board ensures transparency, fairness, and integrity throughout the publication process.
Section E: Publishing Ethics and Research Integrity
The Editorial Board of DAHUDER Medical Journal fully complies with the principles and guidelines of the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the World Association of Medical Editors (WAME).
1. Editors, associate editors, and members of the editorial board are allowed to submit their own manuscripts to the journal. However, they cannot access or participate in any stage of the editorial or peer-review process related to their own submissions. For such manuscripts, all editorial privileges and system permissions of the author-editor are automatically restricted, and the editorial process is handled independently by another qualified editor or guest editor to ensure transparency and impartiality.
2. All parties involved—authors, reviewers, editors, and publishers—must adhere to the ethical standards set by COPE.
3. Manuscripts found to contain plagiarized, fabricated, or manipulated data will be rejected or retracted, and the authors’ institutions may be informed.
4. Authors may not make major modifications to their manuscripts after acceptance without the editorial board’s approval.
5. All corrections, retractions, or clarifications will be published transparently and promptly.
6. Complaints, appeals, or ethical concerns will be handled according to COPE procedures.
7. The journal strongly supports open science, research transparency, and data sharing in accordance with FAIR principles (Findable, Accessible, Interoperable, Reusable).
Section F: Use of Artificial Intelligence in Scientific Writing and Research
1. Authors must disclose any use of Artificial Intelligence (AI) tools (e.g., ChatGPT, language models, image or data generation software) in the Methods or Acknowledgments section.
2. AI tools cannot be listed as authors and must not replace human scholarly judgment or interpretation.
3. The use of AI is acceptable only for technical assistance, such as improving language, checking grammar, or formatting references, provided it does not affect the integrity or originality of the research.
4. Authors are fully responsible for the accuracy and validity of any content generated or assisted by AI.
5. Editors and reviewers may use AI-assisted tools only for technical screening (e.g., plagiarism detection, language check) but not for decision-making.
6. Undisclosed or inappropriate use of AI in manuscript preparation or peer review will be treated as a breach of publication ethics.
Price Policy
• DAHUDER Medical Journal does not charge any fees for article submission, peer review, editorial processing, page layout, or publication (including page or color charges).
• DAHUDER MJ does not pay any fees or honoraria to authors, reviewers, editors, or editorial board members.
• All articles are free to read and download.
• DAHUDER MJ is an open-access journal and does not require any subscription fees.
• DAHUDER MJ is a signatory to the Budapest Open Access Initiative (BOAI) and adheres to the Open Access principles set out in this initiative.
• All articles are preserved via the LOCKSS (Lots Of Copies Keep Stuff Safe) system through TÜBİTAK ULAKBİM DergiPark.
• In line with its publication policy, the journal does not accept announcements, advertisements, sponsorships, or similar content.
• The journal does not offer a reprint service for professional-quality reproductions of articles.
• All expenses of DAHUDER MJ are covered by the publisher.
Indexes
Other Indexes
Journal Boards
Editorial Board
Toxicology, Cardiology, Internal Diseases, Nanotoxicology, Health and Safety
Assistant Editor
Internal Diseases
Editorial Board_eski
Cellular Interactions, Proteomics and Intermolecular Interactions, Medical Pharmacology, Biologically Active Molecules, Biomolecular Modelling and Design, Cheminformatics and Quantitative Structure-Activity Relationships
Internal Diseases
Internal Diseases
Internal Diseases, Medical Education
Respiratory Diseases, Endocrinology, Gastroenterology and Hepatology, Geriatrics and Gerontology, Internal Diseases, Rural Clinical Health, Clinimetrics, Nefroloji, Intensive Care, Clinical Sciences (Other)
Internal Diseases
Internal Diseases
Immunology (Other), Haematology, Endocrinology, Internal Diseases, Clinical Oncology, Rheumatology and Arthritis
Internal Diseases
Internal Diseases
Internal Diseases
Internal Diseases
Health Sciences
Internal Diseases
Internal Diseases
Internal Diseases
Internal Diseases
Internal Diseases
Internal Diseases
Internal Diseases
Internal Diseases
INDEXING & ABSTRACTING & ARCHIVING
DAHUDER Medical Journal, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
2025 -https://dahuder.org/